Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

Saved in:
Bibliographic Details
Main Authors: Ludwig, Heinz (Author) , Goldschmidt, Hartmut (Author)
Format: Article (Journal) Editorial
Language:English
Published: 17 March 2017
In: Leukemia and lymphoma
Year: 2017, Volume: 58, Issue: 10, Pages: 2501-2504
ISSN:1029-2403
DOI:10.1080/10428194.2017.1298755
Online Access:Verlag, Volltext: https://doi.org/10.1080/10428194.2017.1298755
Get full text
Author Notes:Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee-Joo Chng, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi H. Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng & Douglas Joshua
Description
Item Description:Gesehen am 23.05.2018
Physical Description:Online Resource
ISSN:1029-2403
DOI:10.1080/10428194.2017.1298755